Page last updated: 2024-09-04

carbapenems and E coli Infections

carbapenems has been researched along with E coli Infections in 246 studies

Research

Studies (246)

TimeframeStudies, this research(%)All Research%
pre-19903 (1.22)18.7374
1990's6 (2.44)18.2507
2000's22 (8.94)29.6817
2010's147 (59.76)24.3611
2020's68 (27.64)2.80

Authors

AuthorsStudies
Chan, EW; Chen, S; Dong, N; Li, R; Liu, X; Ye, L1
Akalın, H; Eser, ÖK; Gürpınar, Ö; Köksal, İ; Otlu, B; Özakın, C; Ünal, S; Zarakolu, P1
Al-Mir, H; Drapeau, A; Haenni, M; Hamze, M; Madec, JY; Osman, M1
Guo, L; Li, F; Li, X; Wang, L; Yang, J; Ye, K; Ye, L1
Bertoncelli, A; Mazzariol, A; Righetti, V1
Dong, H; Li, X; Liu, C; Ming, L; Xu, M1
Enoki, Y; Hayashi, M; Igarashi, Y; Kojima, N; Liu, X; Matsumoto, K; Mizukami, Y; Morita, T; Nakamura, T; Taguchi, K; Takemura, W; Tashiro, S; Yokoyama, Y1
Amolini, C; Boroni, G; Caruso, A; Corbellini, S; De Francesco, MA; Gurrieri, F; Mascherpa, M; Piccinelli, G; Scaltriti, E1
Ali, A; Hasan, B; Hassan, B; Khan, AU; Mohsin, M; Swedberg, G1
Li, Y; Wang, S; Zhang, R1
Bakhtiar, A; Chong, CW; Khalid, KE; Khan, RA; Tan, SY1
Allman, E; Blomberg, B; Goodman, RN; Hubbard, ATM; Kibwana, U; Langeland, N; Manyahi, J; Moyo, SJ; Roberts, AP1
Neville, LF; Rendell, JT; Shalit, I; Warn, PA1
Anaraki, S; Barry, D; Cherian, BP; Cole, K; Cummins, M; Didelot, X; Jauneikaite, E; Lasalle, F; Ledda, A; Manuel, R; Paul, J; Rosmarin, C; Shaw, LP; Stoesser, N; Turton, J; Wareham, D1
Dong, N; Guo, X; Hu, X; Jin, L; Li, P; Lin, Y; Qiu, S; Song, H; Sun, Y; Wang, X; Xiang, Y; Yang, L; Zhang, C; Zhang, L1
Al-Bayati, M; Samarasinghe, S1
Deng, G; Feng, M; Gao, Y; Hao, F; He, P; Liu, X; Liu, Y; Miao, Q; Zhang, N; Zhang, Z; Zhao, L; Zhu, J1
Chen, J; Huang, XB; Lv, Y; Wang, C; Wei, DQ; Wu, JY; Xiang, Q1
Bauer, MJ; Flora, MS; Forde, BM; Habib, ZH; Harris, P; Islam, K; Roberts, JA; Shirin, T; Sime, FB; Wallis, SC1
Vital, PG; Zara, ES1
Doi, Y; Enokida, T; Harada, S; Hayama, B; Hoashi, K; Ohkushi, D; Sakurai, A; Suzuki, M; Takeda, K; Takehana, K1
Akeda, Y; Hamada, S; Iida, T; Matsumoto, Y; Motooka, D; Sakamoto, N; Sugawara, Y1
Deligios, M; Fiamma, M; Paglietti, B; Rubino, S; Sacarlal, J; Santona, A; Simbine, SE; Sumbana, JJ; Taviani, E; Zimba, T1
Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C1
Guzmán-Cedillo, AE; Jang, BH; Kang, JH; Kwon, S; Lee, MS; Park, SJ1
Guo, C; Guo, X; Huang, S; Li, M; Lv, C; Shang, J; Sun, B; Zhang, W; Zhou, N; Zhu, Y1
Castanheira, M; Cotroneo, N; Critchley, I; Hubler, C; Kantro, V; Kimbrough, JH; Mendes, RE1
Dong, L; Feng, J; Geng, H; Gu, S; He, C; Hou, G; Ji, T; Kang, W; Lai, J; Li, Y; Li, Z; Pang, D; Wang, Y; Zhao, L; Zhu, X; Zhu, Y1
Acampora, A; Albano, R; Buonsenso, D; Ferrari, V; Fiori, B; Pata, D; Sanguinetti, M; Spanu, T; Valentini, P1
Arı, O; Durmaz, R; Sancak, B1
Chen, L; He, J; Li, X; Pan, H; Quan, J; Wang, Q; Zhang, X1
Dong, Y; Ed-Dra, A; Lin, H; Lin, J; Ma, J; Tang, B; Wu, J; Yang, H; Yue, M1
Berglund, B; Li, Q; Li, X; Meng, M; Wang, D; Zhao, L; Zou, H1
Chen, YH; Cheng, NC; Cheng, Y; Chien, KL; Fang, CT; Hsueh, PR; Tai, HC; Wang, SH1
Bai, Y; Chen, R; Hao, Y; Lu, X; Si, Z; Song, Z; Wan, Z; Wang, G; Wang, Q; Wang, Y; Zhang, M1
Gao, GL; He, WY; Liu, JH; Lu, YY; Lv, LC; Pu, WX; Zhuang, ZL; Zhuo, C1
Ahlstrom, CA; Bonnedahl, J; Ramey, AM; Sandegren, L; Woksepp, H1
Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ1
Birinci, A; Ertokatlı, M; Güney, DB; Hacıeminoğlu Ülker, K; Karacan Temür, G; Tanrıverdi Çaycı, Y1
Abdul Jabar, K; Abu Bakar, S; Ahmed Khan, A; Chong, CW; Harun, A; Ismail, Z; Jasni, AS; Karunakaran, R; Kong, ZX; Lau, MY; Lee, YQ; Leong, KC; Lim, VKE; Mak, ST; Masri, SN; Md Noor, SS; Mohd Taib, N; Ngoi, ST; Ponnampalavanar, S; Ramli, R; Salleh, SA; Tan, SC; Tee, LH; Teh, CSJ; Tengku Jamaluddin, TZM; Woon, JJ; Yap, PSX1
Alsharapy, SA; Bertrand, X; Brasme, L; Cholley, P; De Champs, C; Gharout-Sait, A; Guillard, T; Moghram, GS; Muggeo, A; Touati, A1
Antonelli, A; Camarlinghi, G; Coppi, M; Giani, T; Mattei, R; Nardone, M; Parisio, EM; Riccobono, E; Rossolini, GM1
Bhattacharjee, A; Bhowmik, D; Bora, D; Chakravarty, A; Chanda, DD; Chetri, S; Pandey, P; Paul, D1
Fihman, V; Lafaurie, M; Lepeule, R; Lescure, X; Lesprit, P; Nguyen, Y; Oubaya, N; Senard, O; Therby, A1
Choi, Q; Koo, SH; Kwon, GC; Park, Y1
Choi, J; Dantas, G; Das, S; Gandra, S; Green, SJ; Harazin, M; McElvania, E; Singh, KS; Thomson, RB1
Guo, Y; Lu, N; Lv, Q; Qiu, J; Sun, X; Wang, J; Zhang, P; Zhou, Y1
Ceric, O; Cole, SD; Peak, L; Rankin, SC; Reimschuessel, R; Tyson, GH1
Anandan, S; Daniel, JLK; Devanga Ragupathi, NK; Iyadurai, R; Muthuirulandi Sethuvel, DP; Mutreja, A; Neeravi, AR; Sathyendra, S; Vasudevan, K; Veeraraghavan, B1
Bhattacharjee, A; Bhowmik, D; Chakravarty, A; Chanda, DD; Chetri, S; Das, BJ1
Almaeen, AH; Bandy, A1
Han, S; Hong, CK; Kim, HS; Kim, J; Kim, JS; Lee, SM; Oh, YH; Park, J; Park, SH; Yu, JK1
Gao, B; Sheng, Q; Tu, M; Wang, M; Wang, P1
Board, MM; Crespo, R; Faux, C; Guard, J; Paul, NC; Shah, DH1
Berk, H; Kizilates, F; Otlu, B; Oztoprak, N; Yakupogullari, Y1
Alba, P; Battisti, A; Buccella, C; Carfora, V; Dell'Aira, E; Di Matteo, P; Diaconu, EL; Franco, A; Onorati, R; Sorbara, L; Stravino, F1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y1
Deemer, K; Fronczek, C; Grey, J; Marr, K1
Chakraborty, T; Falgenhauer, J; Falgenhauer, L; Hauri, AM; Heinmüller, P; Imirzalioglu, C; Nordmann, P; Yao, Y1
Al-Azri, S; Al-Farsi, HM; Al-Jardani, A; Al-Muharrmi, Z; Camporeale, A; Giske, CG; Ininbergs, K1
Hao, Q; Ho, PL; Kao, RY; Li, H; Sun, H; Wang, H; Wang, M; Wang, R; Wong, YT; Yan, A; Zhang, Q1
Boutin, S; Heeg, K; Miethke, T; Nurjadi, D; Welker, S1
Cisera, K; Hughes, C; Rogers, B; Taylor, L; Xie, O1
Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K1
Katip, W; Oberdorfer, P; Uitrakul, S; Yoodee, J1
de Haan, A; Hendrickx, APA; Landman, F; Schouls, LM; van Santen-Verheuvel, MG; Witteveen, S1
Agga, GE; Martin, RS; Silva, PJ1
Angulmaduwa, S; De Silva, K; Ekanayake, A; Ip, M; Kalupahana, R; Kuthubdeen, S; Liyanapathirana, V; Munasinghe, T; Subhasinghe, S; Vidanapathirana, G1
Dao, TD; Hasebe, F; Hirabayashi, A; Kasuga, I; Shibayama, K; Suzuki, M; Takemura, T; Thanh, NH; Tran, HH; Trang, LT1
Beloeil, PA; Bortolaia, V; Guerra, B; Hansen, IM; Hendriksen, RS; Hoffmann, M; Kjeldgaard, JS; Leekitcharoenphon, P; Milita, NM; Mordhorst, H; Nicorescu, I; Romascu, L; Ronco, T; Svendsen, CA; Vaduva, AM1
Amudhan, M; Mythreyee, M; Sekar, R; Srivani, S1
Cherng, BPZ; Choon, RFK; De, PP; Deepak, RN; Fisher, D; Hsu, LY; Khong, WX; Koh, TH; Krishnan, PU; Kurup, A; Lam, CW; Lee, JJ; Lin, RTP; Ling, ML; Marimuthu, K; Ng, OT; Ong, RT; Ooi, ST; Pada, SK; Peng, BAS; Sim, NTW; Smitasin, N; Tan, EL; Tan, TY; Teo, J; Teo, YY; Thoon, KC; Van La, M; Venkatachalam, I; Young, B1
Abe, Y; Fukuchi, K; Hashimoto, K; Hibino, S; Inan-Erdogan, I; Itabashi, K; Matsuhashi, K; Ogawa, Y; Sakurai, S; Ugajin, K; Wakabayashi, H; Watanabe, Y1
Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR1
Bauerfeind, R; Ewers, C; Prenger-Berninghoff, E; Pulss, S; Semmler, T1
Ding, Y; Feng, Y; Hassan, B; Li, J; Li, XP; Lin, J; Sun, J; Wang, Q1
Cui, S; Ding, H; Luo, H; Luo, R; Luo, Y; Ren, X; Ye, L; Zhang, Y1
Arlet, G; Ben Hassine, I; Chachaty, E; Decré, D; Forget, S; Jardak, T; Woerther, PL1
Fujimoto, H; Kakeya, H; Kaneko, Y; Namikawa, H; Oinuma, KI; Shuto, T; Takemoto, Y; Tochino, Y; Yamada, K1
Akeda, Y; Aye, MM; Hagiya, H; Hamada, S; Motooka, D; Nakamura, S; Nishi, I; Okada, K; Sakamoto, N; Sugawara, Y; Takeuchi, D; Tomono, K; Yamamoto, N; Yoshida, H; Zin, KN1
Castanheira, M; Davis, AP; Deshpande, LM; Le, J; Turner, N1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yang, KS; Yoon, YK1
Abdala, E; Cury, AP; da Silva Duarte, AJ; da Silva, AM; Girardello, R; Martins, LF; Morais, C; Rossi, F; Setubal, JC1
Batra, J; Doda, A; Gandhoke, I; Grover, SS; Gupta, N; Hans, C; Khare, S1
Cao, H; Chow, KH; Ho, PL; Lai, EL; Law, PY; Liu, MC; Wang, Y1
Khedkar, S; Khedkar, U; Lind, F; Nerkar, SS; Odsbu, I; Orsini, N; Stålsby Lundborg, C; Tamhankar, AJ1
Krishnaswamy, N; Murugan, MS; Nirupama, KR; O R, VK; Pruthvishree, BS; Singh, BR; Sinha, DK1
Asadi Karam, MR; Bouzari, S; Habibi, M; Shahbazi, S; Talebi, A1
Gupta, S; Mukhopadhyay, C; Pathak, A; Prasad, KN; Rahman, M; Rai, RP; Singh, A; Singh, S1
Du, X; Fu, Y; Hu, Q; Huang, D; Li, X; Shen, M; Wang, D; Yu, Y; Zhou, Y1
Adak, S; Bulagonda, EP; Khamari, B; Mahalingam, N; Manivannan, B; Siddaramappa, S1
Borghi, M; Bueno Freitas, L; Cruz Spano, L; Pinto Schuenck, R; Santos Almeida, M; Soares Jardim Lacerda Batista, J; Tonini, MA1
Kato, A; Kirikae, T; Miyairi, I; Sugahara, Y; Tada, T; Uchida, H1
Eklund, M; Grönthal, T; Jalava, J; Nykäsenoja, S; Österblad, M; Pekkanen, K; Rantala, M1
Feng, Y; Lei, S; Liu, W; Mao, J; Sun, J; Wang, W1
Aziz, FN1
Alousi, S; Arabaghian, H; Araj, GF; Dagher, C; Salloum, T; Tokajian, S1
Hayden, MK; Won, SY1
Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y; Zhao, D1
Jia, H; Li, B; Liu, J; Liu, K; Ma, Z; Qiu, Y; Shao, D; Tong, H; Wei, J; Yao, X1
Cheng, J; Feng, X; Liu, HM; Qin, S; Wang, P1
Gao, Y; Guo, R; Lu, L; Shen, H; Yu, Y; Zhu, C1
Bedenić, B; Drenjančević, D; Kopić, J; Presečki-Stanko, A; Talapko, J; Tomić Paradžik, M; Zarfel, G1
An, JH; Gong, Y; Han, S; Hong, CK; Jin, YH; Jung, K; Jung, SW; Kim, DW; Kim, HS; Kim, IY; Kim, J; Kim, JS; Kim, S; Lee, JH; Park, JH; Park, SH1
Jin, X; Jin, Y; Wang, K; Wang, Y; Yu, J; Zhang, Q1
Cao, L; Chang, J; Ji, X; Luo, Q; Lyu, W; Qian, M; Tang, B; Xia, X; Xu, H; Yang, H; Zhang, Q1
Cusack, TP; Dance, DAB; Duangmala, K; Hopkins, KL; Phan, HTT; Phimolsarnnousith, V; Phoumin, P; Shetty, N; Stoesser, N; Turton, J; Woodford, N1
Huang, J; Huang, X; Huang, Y; Liu, E; Liu, JH; Lu, J; Lv, L; Song, Q; Wan, M; Xun, H; Zhang, Q; Zhang, Z; Zhuang, Z; Zhuo, C1
Bruderer, V; Greiner, M; Imkamp, F; Keller, PM; Mancini, S1
Goodman, JL; Hartley, DM; Koch, M; Malchione, MD; Torres, LM1
Fang, C; Hou, Z; Hu, Y; Li, M; Lu, L; Luo, X; Ma, B; Wang, M; Xue, X; Zhou, Y1
Bertrand, X; Chirouze, C; Cholley, P; Fournier, D; Leroy, J; Plésiat, P; Talon, D1
Hernández, E; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I1
Li, W; Liu, G; Liu, Z; Lu, F; Ma, Y; Pan, J; Qi, J; Sun, S; Wang, J; Yu, Y; Zhang, T; Zhao, B1
Lastovetska, O; Low, DE; Macmullin, G; Melano, RG; Patel, SN; Stacey-Works, T; Tijet, N; Vermeiren, C; Wenzel, P1
Bethe, A; Ewers, C; Guenther, S; Hassdenteufel, E; Pfeifer, Y; Prenger-Berninghoff, E; Scheufen, S; Stamm, I; Stolle, I1
Chuang, YC; Fung, CP; Lin, JC; Lu, PL; Ma, L; Siu, LK; Wang, JT; Wu, TL1
Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N1
Al Johani, SM; Al Salman, J; Al-Abri, S; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Kutbi, AH; Paterson, DL; Sartor, AL; Schlebusch, S; Sidjabat, HE; Walsh, TR; Zowawi, HM1
Farrell, R; Kopacz, J; Mariano, N; Piracha, N; Prasad, N; Segal-Maurer, S; Shakil, J; Tarasuk, A; Urban, C; Wang, G1
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Tada, T1
Doi, Y; Qureshi, ZA1
Bille, E; Emirian, A; Groh, M; Guet-Revillet, H; Join-Lambert, O; Jullien, V; Nebbad-Lechani, B; Weiss, E; Zahar, JR1
Ahn, JY; Ann, HW; Choi, H; Choi, JY; Han, SH; Jeon, Y; Jeong, SJ; Kim, JH; Kim, JK; Kim, JM; Kim, MH; Kim, SB; Ku, NS; Lee, K; Song, JE; Song, YG; Yong, D1
Iredell, JR; Partridge, SR; Tagg, KA1
Acar, A; Aktas, Z; Budak, S; Erdem, H; Gorenek, L; Oncul, O; Ozyurt, M; Turhan, V1
Chandran, SP; Diwan, V; Joseph, BV; Lundborg, CS; Macaden, R; Mundayoor, S; Rosales-Klintz, S; Tamhankar, AJ1
Chang, YY; Chuang, YC; Fung, CP; Huang, LJ; Lin, JC; Lin, YT; Lu, PL; Siu, LK; Wang, JT; Wang, LS; Wu, TL1
Crandon, JL; MacVane, SH; Nichols, WW; Nicolau, DP1
Hampton, T1
Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG1
Boyd, D; Bryce, E; Embree, J; Fuller, J; Gravel, D; Katz, K; Kibsey, P; Kuhn, M; Langley, J; Mataseje, L; Mitchell, R; Mulvey, M; Roscoe, D; Simor, A; Taylor, G; Thomas, E; Turgeon, N1
Garrec, H; Jarlier, V; Lafeuille, E; Laouira, S; Leconte, J; Robert, J; Sougakoff, W; Soulier-Escrihuela, O; Tourret, J1
Dua, KS; Edmiston, CE; Khan, AH; Massey, BT; Oh, YS; Saeian, K; Smith, ZL1
Huang, SF; Pu, SL; Sun, JD; Yang, SS; Zhang, CM; Zhang, LP1
Hong, MT; Seifert, CF1
Baliga, C; D'Angeli, M; Duchin, J; Eckmann, K; Gluck, M; Kang, MG; Kay, M; Ross, AS; Swoveland, J; Verma, P; Weissman, SJ; Wendorf, KA1
Rutala, WA; Weber, DJ1
Hiraki, K; Murakami, N; Sugawara, T; Uetake, N1
Eslami, G; Langaee, T; Rafati, M; Rafiei, A; Rezai, MS; Salehifar, E; Shafahi, K1
Adámková, V; Balejova, M; Bergerová, T; Chmelařová, E; Dvořáková, L; Hrabák, J; Jakubů, V; Ježek, P; Kabelíková, P; Kolář, M; Papagiannitsis, C; Paterová, P; Študentová, V; Tejkalová, R; Žemličková, H1
Carbonnelle, E; Compain, F; Geri, G; Kernéis, S; Lavollay, M; Mainardi, JL; Rostane, H; Valade, S1
Batbaatar, G; Bolormaa, E; Huang, AH; Huang, YT; Kao, CY; Khosbayar, T; Udval, U; Urangoo, Z; Wu, HM; Wu, JJ; Yan, JJ1
Delory, T; Emirian, A; Groh, M; Lecuyer, H; Lesprit, P; Pilmis, B; Weiss, E; Zahar, JR1
Chen, FJ; Chien, CC; Lee, CH; Li, CC; Liu, JW; Su, LH; Tang, YF1
Bethel, CR; Bonomo, RA; Doi, Y; Endimiani, A; Kasraian, S; Pires, J; Sendi, P; Taracila, M; Tinguely, R1
Hsueh, PR; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC; Lo, CL1
Han, SB; Jeong, DC; Kang, JH; Lee, SC; Lee, SY1
Kamath, S; M Shenoy, S; Sinha, R1
Cui, T; Su, M; Wang, J; Yan, H; Yang, H; Yang, Z; Yao, Q; Zhan, Y; Zhao, P1
Dong, F; Guo, L; Li, S; Liu, G; Liu, L1
Aberkane, S; Bouzinbi, N; Compain, F; Decré, D; Godreuil, S; Hide, M; Jean-Pierre, H; Ouédraogo, AS; Ouédraogo-Traoré, R; Sangaré, L; Sanou, M; Solassol, J; Vendrell, J1
Cipolla, A; D'Abramo, A; De Angelis, M; Favaro, M; Ferretti, G; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Vullo, V1
Ahlstedt, E; Caceres, M; Hasan, B; Hernandez, J; Järhult, JD; Laurell, K; Rakib, MM1
Angkititrakul, S; Chaimanee, P; Chanawong, A; Charoensri, N; Chetchotisakd, P; Lulitanond, A; Lunha, K; Saenjamla, P; Wilailuckana, C; Wonglakorn, L1
Boudehouche, W; Haenni, M; Madec, JY; Saras, E; Touati, A; Yaici, L1
Chen, YB; Huang, JA; Zhang, M1
Kumar, M; Saha, S; Subudhi, E1
Chavda, KD; Chen, L; Dever, LL; Kreiswirth, BN; Mathema, B; Mediavilla, JR; Patrawalla, A; Vinnard, C1
Chan, EW; Chen, K; Chen, S; Li, R; Lin, D; Xie, M1
Cheng, GY; Guan, R; Jiang, W; Kong, LH; Lei, CW; Liu, BH; Ma, SZ; Men, S; Wang, HN; Wang, YX; Yuan, QW; Zhou, WC1
Boisson, MN; Boulouis, HJ; Haenni, M; Madec, JY; Médaille, C; Melo, LC; Saras, E1
Boyanova, L; Kaneva, R; Markovska, R; Mitev, V; Mitov, I; Pencheva, D; Stankova, P; Stoeva, T1
Dobashi, H; Imataki, O; Kadowaki, N; Kuwahara, T; Matsuka, H; Mori, H; Nakayama-Imaohji, H; Ohue, Y; Uchida, S; Uemura, M1
Duan, J; Fu, C; Gong, R; Huang, X; Li, C; Liu, S; Liu, Y; Meng, X; Wu, A; Xiong, X; Zhang, Y; Zhou, P1
Alonso-Isa, M; Benítez-Sala, R; García-Rojo, E; Gil-Moradillo, J; González-Padilla, DA; Justo-Quintas, J; Lara-Isla, A; Medina-Polo, J; Passas-Martínez, JB; Sopeña-Sutil, R; Tejido-Sánchez, Á1
Bhattacharjee, A; Chakravarty, A; Choudhury, NA; Dhar, D; Ingti, B; Maurya, AP; Paul, D1
Bhattacharjee, A; Garg, A; Paul, D1
Al-Abri, SS; Al-Jardani, A; Aldeesi, Z; Carattoli, A; Darwish, D; Ghazawi, A; Hashmey, R; Jamal, W; Pál, T; Rotimi, V; Sonnevend, Á; Villa, L1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Fernando, MM; Gunathilake, MP; Luke, WA; Miththinda, JK; Premaratna, R; Sebastiampillai, BS; Silva, FH; Wickramasinghe, RD1
Ahmed, AM; Hara, T; Ikeda, M; Kayama, S; Khalifa, HO; Kuroo, Y; Shimamoto, T; Soliman, AM; Sugai, M1
Chen, CC; Chuang, YC; Lai, CC; Tang, HJ1
Apisarnthanarak, A; Kiratisin, P; Mundy, LM1
Choi, SH; Chung, JW; Jeon, MH; Jeong, JY; Kim, YS; Kwak, YG; Lee, SO; Woo, JH1
Dropa, M; Elmor de Araújo, MR; Grinbaum, RS; Lincopan, N; Mamizuka, EM; Matté, MH; Neves, P; Pavez, M1
Lortholary, O; Martin, C; Nordmann, P; Plesiat, P; Potel, G; Zahar, JR1
Protonotariou, E; Sofianou, D; Vitti, D1
Abid, J; Adams-Haduch, JM; Doi, Y; Dossenback, DA; Halstead, DC; Paterson, DL; Sellen, TJ1
Baudry, PJ; Cox, L; Hoban, DJ; Karlowsky, JA; Tailor, F; Zhanel, GG1
Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC1
Kiratisin, P; Leelaporn, A; Leelarasmee, A; Netikul, T1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S1
Mariano, N; Rahal, JJ; Urban, C1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ1
Ko, WC; Lee, CC; Wu, JJ; Yan, JJ; Yang, FC1
Fluit, AC; Leverstein-Van Hall, MA; Stuart, JC; Tersmette, T; Versteeg, D; Voets, GM1
Koemtzidou, E; Lebessi, E; Papadimitriou, M; Ranellou, K; Tsakris, A; Voulgari, E1
Arda, B; Pullukcu, H; Senol, S; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T1
Du, X; Jiang, X; Li, G; Wang, Y; Wei, Q; Zhao, Y1
Chryssouli, Z; Galani, I; Giamarellos-Bourboulis, E; Giamarellou, H; Konstantinidou, E; Pefanis, A; Souli, M; Tsaganos, T; Tzepi, I1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F1
Goff, DA; Parbhoo, RK; Schafer, JJ; Winters, HA1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC1
Chang, HJ; Chia, JH; Hsu, PC; Kuo, AJ; Lee, MH; Wu, TL; Yang, CC1
Alış, EE; Cengiz, M; Ekici, S; Turan, G1
Sekar, U; Shanthi, M1
Akpaka, PE; Legall, B; Padman, J1
Courcol, R; Cuzon, G; Gaillot, O; Naas, T; Nordmann, P1
Baba, S; Fujita, T; Iwamura, M; Kimura, M; Kurosaka, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H1
Bhusal, Y; Mihu, CN; Rolston, KV; Tarrand, JJ1
Hornsey, M; Phee, L; Wareham, DW1
Chen, G; Hu, ZQ; Ito, R; Kimura, S; Zhao, WH1
López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C1
Acosta, F; Cottagnoud, M; Cottagnoud, P; Egerman, U; Laeuffer, JM; Stucki, A1
Chau, F; Fantin, B; Le, P; Lefort, A; Lepeule, R; Massias, L; Nucci, A; Ruppé, E1
Dalekos, GN; Malli, E; Mavroidi, A; Miriagou, V; Petinaki, E; Stefos, A; Tzouvelekis, LS1
Bauernfeind, A; Bojkova, K; Gergova, R; Ivanova, D; Keuleyan, E; Markova, B; Markovska, R; Mitov, I; Schneider, I; Sredkova, M; Stoeva, T1
Balan, G; Ho, WS; Koh, XP; Kong, BH; Lim, KT; Puthucheary, S; Tan, LK; Thong, KL; Yeo, CC1
Chen, H; Chen, M; Liu, Y; Wang, H; Zhang, F; Zhao, C1
Ikeda, Y; Koseki, T; Mamiya, T; Mouri, A; Nabeshima, T; Narusawa, S; Nishiyama, H1
Hsueh, PR; Lee, YJ; Lin, YC; Liu, HY; Wu, HH1
Araj, GF; Baroud, M; El-Herte, RI; Kanafani, ZA; Kanj, SS; Matar, GM1
Chan, KS; Choudhury, S; Koh, TH1
Brun-Buisson, C; Derde, LP; Legrand, P; Lesprit, P; Razazi, K; Verachten, M1
Benenson, S; Block, C; Hidalgo-Grass, C; Moses, AE; Strahilevitz, J; Temper, V; Warburg, G1
Chan, JF; Cheng, VC; Ho, PL; Lo, WU; To, KK; Tse, H1
Anh, DD; Duong, TN; Hien, NT; Hoang, TH; Izumiya, H; Minh, NB; Ohnishi, M; Phuong, TT; Shibayama, K; Son, TH; Wertheim, H1
Ahmed, S; Cherabuddi, K; Chundi, V; Hayden, MK; Lin, MY; Lolans, K; McNally, M; Norris, A; Odeh, R; Prabaker, K; Weinstein, RA1
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S1
Chlebicki, MP; Oh, HM1
Chang, LY; Hsueh, PR; Huang, LM; Lee, CY; Lee, PI; Lu, CY; Shao, PL; Wang, CY; Wu, TZ; Yang, CY1
Cakir, B; Hascelik, G; Metan, G; Uzun, O; Zarakolu, P1
Mikamo, H; Totsuka, K1
Chiu, S; Chou, YH; Huang, YC; Lien, RI; Lin, TY1
Aguilar, J; Almela, M; Balasso, V; López, F; Marco, F; Martínez, JA; Mensa, J; Pozo, L; Soriano, A1
Bratu, S; Brooks, S; Burney, S; Gupta, J; Kochar, S; Landman, D; Quale, J1
Yoshida, A1
Altindis, M; Caylan, R; Demirdağ, K; Günaydin, M; Gündes, S; Hoşoğlu, S; Karadenizli, A; Kolayli, F; Ucmak, H1
Ip, M; Kei, HW; Lau, WC; Lee, N; Marasinghe, T; Wong, KY; You, JH1
Ko, WC; Liu, YF; Tsai, SH; Wu, JJ; Yan, JJ1
Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y1
Edwards, JR; Nairn, K; Shepherd, GL1
Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C1
Bitha, P; Li, Z; Lin, YI1
Jeong, HJ; Kim, BJ; Kim, EJ; Kim, JH; Kwak, HJ; Lee, CH; Pyun, DK1
Hayasaki, Y; Hua, YX; Izumi, K; Mikamo, H; Sato, Y; Tamaya, T1
Iwatsubo, E; Kawakami, Y; Manabe, N; Matsumoto, T; Takahashi, K1
Fung-Tomc, J; Mastalerz, H; Menard, M; Ruediger, E1
Hopkins, JA; Lami, JL; Wilson, SE1
Basker, MJ; Corbett, DF; Coulton, S; Southgate, R1
Dworkin, RJ; Kennedy, SL; Sachdeva, M; Sande, MA; Tureen, JH1
Edwards, JR; Nairn, K; Williams, S1
Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T1

Reviews

8 review(s) available for carbapenems and E coli Infections

ArticleYear
Antimicrobial resistance and molecular epidemiology of carbapenem-resistant Escherichia coli from urinary tract infections in Shandong, China.
    International microbiology : the official journal of the Spanish Society for Microbiology, 2023, Volume: 26, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Molecular Epidemiology; Phylogeny; Urinary Tract Infections; Uropathogenic Escherichia coli

2023
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2023, Jun-08

    Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing

2023
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: Review and mapping of emerging and overlapping challenges.
    International journal of antimicrobial agents, 2019, Volume: 54, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia, Southeastern; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Genotype; Humans; Infant; Infant, Newborn; Klebsiella Infections; Male; Middle Aged; Young Adult

2019
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
    Expert review of anti-infective therapy, 2014, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States

2014
Addressing the challenge of extended-spectrum beta-lactamases.
    Current opinion in investigational drugs (London, England : 2000), 2009, Volume: 10, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome; Urinary Tract Infections

2009
Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients.
    The Annals of pharmacotherapy, 2011, Volume: 45, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Carbapenems; Escherichia coli Infections; Female; Gram-Negative Bacteria; Humans; Kidney Transplantation; Klebsiella Infections; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pancreas Transplantation; Recurrence; Retrospective Studies; Time Factors; Treatment Outcome

2011
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2007, Nov-10, Volume: 96, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections

2007

Trials

5 trial(s) available for carbapenems and E coli Infections

ArticleYear
Comparison of the Treatment Outcome of Piperacillin-Tazobactam versus Carbapenems for Patients with Bacteremia Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli in Areas with Low Frequency of Coproduction of OXA-1: a Preliminary Analysis.
    Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Piperacillin, Tazobactam Drug Combination; Treatment Outcome

2022
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2023, Jun-08

    Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing

2023
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
    International journal of antimicrobial agents, 2014, Volume: 43, Issue:4

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult

2014
Adjunctive antimicrobials in surgery of soft tissue infections: evaluation of cephalosporins and carbapenems.
    The American surgeon, 1991, Volume: 57, Issue:12

    Topics: Adult; Aged; Bacterial Infections; Carbapenems; Cefmetazole; Cefoperazone; Cefotetan; Cefoxitin; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Prospective Studies; Remission Induction; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections; Thienamycins

1991

Other Studies

235 other study(ies) available for carbapenems and E coli Infections

ArticleYear
Complete Genetic Analysis of Plasmids Carried by Two Nonclonal
    Microbiology spectrum, 2021, 10-31, Volume: 9, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Foodborne Diseases; Gene Transfer, Horizontal; Genome, Bacterial; Humans; Meat; Microbial Sensitivity Tests; Plasmids; Whole Genome Sequencing

2021
In-vitro activity of fosfomycin against
    Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests

2022
Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon.
    The Journal of antimicrobial chemotherapy, 2021, 11-12, Volume: 76, Issue:12

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Clone Cells; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Lebanon; Microbial Sensitivity Tests; Plasmids

2021
Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015-2017.
    BMC microbiology, 2021, 09-17, Volume: 21, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Whole Genome Sequencing

2021
Characterization of Escherichia coli strains resistant to carbapenems isolated from rectal swab in a multidrug-resistant strains screening programme.
    The new microbiologica, 2021, Volume: 44, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids

2021
Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
    Journal of global antimicrobial resistance, 2022, Volume: 29

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Tertiary Care Centers

2022
Cefmetazole as an Alternative to Carbapenems Against Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Infections Based on In Vitro and In Vivo Pharmacokinetics/Pharmacodynamics Experiments.
    Pharmaceutical research, 2021, Volume: 38, Issue:11

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefmetazole; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Microbial Sensitivity Tests; Neutropenia

2021
Genomic characterisation of Escherichia coli isolates co-producing NDM-5 and OXA-1 from hospitalised patients with invasive infections.
    Journal of global antimicrobial resistance, 2022, Volume: 28

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Genomics; Humans; Microbial Sensitivity Tests

2022
Genomic characterization of high-risk Escherichia coli and Enterobacter hormaechei clones recovered from a single tertiary-care hospital in Pakistan.
    Journal of applied microbiology, 2022, Volume: 132, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Disinfectants; Enterobacter; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Pakistan; Plasmids; Tertiary Care Centers

2022
A Natural Novel Mutation in the
    Microbiology spectrum, 2022, 02-23, Volume: 10, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Mutation; Promoter Regions, Genetic

2022
Correlation between antibiotic consumption and the occurrence of multidrug-resistant organisms in a Malaysian tertiary hospital: a 3-year observational study.
    Scientific reports, 2022, 02-24, Volume: 12, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Inappropriate Prescribing; Klebsiella; Klebsiella Infections; Malaysia; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Tertiary Care Centers

2022
First identification of
    Journal of medical microbiology, 2022, Volume: 71, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; HIV Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Plasmids; Tanzania

2022
Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection model.
    The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Arginine; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Mice; Microbial Sensitivity Tests; Tandem Mass Spectrometry; Urinary Tract Infections; Vancomycin

2022
Hospital outbreak of carbapenem-resistant Enterobacterales associated with a
    Microbial genomics, 2022, Volume: 8, Issue:4

    Topics: beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella pneumoniae; Plasmids

2022
Dissemination of
    Microbial drug resistance (Larchmont, N.Y.), 2022, Volume: 28, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Plasmids

2022
Biofilm and Gene Expression Characteristics of the Carbapenem-Resistant Enterobacterales,
    International journal of environmental research and public health, 2022, 04-14, Volume: 19, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2022
Association between gut microbiome and metabolome in mice suffering from acute carbapenem-resistant Escherichia coli infection.
    Journal of pharmaceutical and biomedical analysis, 2022, Jun-05, Volume: 215

    Topics: Animals; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Gastrointestinal Microbiome; Metabolome; Mice; RNA, Ribosomal, 16S

2022
Different Effects of Antibiotics on
    Microbial drug resistance (Larchmont, N.Y.), 2022, Volume: 28, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Quinolones; Retrospective Studies

2022
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model.
    The Journal of antimicrobial chemotherapy, 2022, 08-25, Volume: 77, Issue:9

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2022
Phylogroup typing and carbapenem resistance of
    Journal of environmental science and health. Part. B, Pesticides, food contaminants, and agricultural wastes, 2022, Volume: 57, Issue:8

    Topics: Animals; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Philippines; Phylogeny

2022
Role of Chromosome- and/or Plasmid-Located
    Microbiology spectrum, 2022, 08-31, Volume: 10, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids

2022
High-risk lineages among extended-spectrum β-lactamase-producing Escherichia coli from extraintestinal infections in Maputo Central Hospital, Mozambique.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefotaxime; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Gentamicins; Hospitals; Humans; Iron; Mozambique; Piperacillin; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.
    Infectious diseases now, 2022, Volume: 52, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections

2022
Human Cell-Camouflaged Nanomagnetic Scavengers Restore Immune Homeostasis in a Rodent Model with Bacteremia.
    Small (Weinheim an der Bergstrasse, Germany), 2022, Volume: 18, Issue:40

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; COVID-19 Drug Treatment; Cytokines; Endotoxins; Escherichia coli; Escherichia coli Infections; Glycophorins; Homeostasis; Humans; Microbial Sensitivity Tests; Opsonin Proteins; Rats; Receptors, Complement; Rodentia; SARS-CoV-2; Viral Envelope Proteins

2022
Dynamic antimicrobial resistant patterns of Escherichia coli from healthy poultry and swine over 10 years in Chongming Island, Shanghai.
    Infectious diseases of poverty, 2022, Sep-16, Volume: 11, Issue:1

    Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Microbial Sensitivity Tests; Penicillins; Polymyxins; Poultry; Sulfonamides; Swine; Tetracyclines

2022
    Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; United States; Urinary Tract Infections

2022
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
    The Journal of infection, 2022, Volume: 85, Issue:5

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Doxycycline; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Multilocus Sequence Typing; Piperacillin; Pregnancy; Tazobactam; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination

2022
Escherichia coli resistance patterns, empiric and targeted antibiotic prescriptions in children: a single center experience.
    Acta bio-medica : Atenei Parmensis, 2022, 10-26, Volume: 93, Issue:5

    Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Humans; Infant; Microbial Sensitivity Tests; Prescriptions; Retrospective Studies

2022
Whole-Genome Sequence Analysis of Carbapenem-Heteroresistant Klebsiella pneumoniae and Escherichia coli Isolates.
    Current microbiology, 2022, Nov-03, Volume: 79, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing

2022
Emergence of coexistence of a novel bla
    Journal of infection and public health, 2022, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids

2022
Genome Assessment of Carbapenem- and Colistin-Resistant
    Cells, 2022, 11-03, Volume: 11, Issue:21

    Topics: Animals; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hospitals; Microbial Sensitivity Tests; Plasmids

2022
High prevalence of Escherichia coli co-harboring conjugative plasmids with colistin- and carbapenem resistance genes in a wastewater treatment plant in China.
    International journal of hygiene and environmental health, 2023, Volume: 250

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence

2023
High mortality risk of type III monomicrobial gram-negative necrotizing fasciitis: The role of extraintestinal pathogenic Escherichia coli (ExPEC) and Klebsiella pneumoniae.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023, Volume: 132

    Topics: Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fasciitis, Necrotizing; Humans; Klebsiella pneumoniae; Streptococcal Infections

2023
Characterization of an International High-Risk Escherichia coli ST410 Clone Coproducing NDM-5 and OXA-181 in a Food Market in China.
    Microbiology spectrum, 2023, 06-15, Volume: 11, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Phylogeny; Plasmids

2023
Exchange of Carbapenem-Resistant Escherichia coli Sequence Type 38 Intercontinentally and among Wild Bird, Human, and Environmental Niches.
    Applied and environmental microbiology, 2023, 06-28, Volume: 89, Issue:6

    Topics: Animals; Animals, Wild; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Birds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Charadriiformes; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests

2023
[Investigation of O25b-ST131 Clone Frequency and Presence of Carbapenem and Fosfomycin Resistance Genes in Escherichia coli Isolates: First Detection of fosA3 from Escherichia coli O25bSTf131 Clone from Türkiye].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests

2023
A multicentre study to determine the
    PeerJ, 2023, Volume: 11

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Malaysia

2023
Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.
    Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Clone Cells; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Hospitals, University; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Quinolones; Yemen

2020
Variable performance of different commercial systems for testing carbapenem susceptibility of KPC carbapenemase-producing Escherichia coli.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Diagnostic Errors; Ertapenem; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Random Amplified Polymorphic DNA Technique

2019
AcrAB-TolC efflux pump system plays a role in carbapenem non-susceptibility in Escherichia coli.
    BMC microbiology, 2019, 09-05, Volume: 19, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Microbial Sensitivity Tests; Tertiary Care Centers; Transcription, Genetic

2019
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:1

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Fever; Humans; Male; Middle Aged; Propensity Score; Retrospective Studies; Urinary Tract Infections

2020
Emergence and transmission of New Delhi metallo-beta-lactamase-5-producing Escherichia coli Sequence Type 361 in a Tertiary Hospital in South Korea.
    Journal of clinical laboratory analysis, 2020, Volume: 34, Issue:2

    Topics: Aged; Aged, 80 and over; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Tertiary Care Centers

2020
Faropenem resistance causes in vitro cross-resistance to carbapenems in ESBL-producing Escherichia coli.
    International journal of antimicrobial agents, 2020, Volume: 55, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Porins

2020
Isoalantolactone restores the sensitivity of gram-negative Enterobacteriaceae carrying MCR-1 to carbapenems.
    Journal of cellular and molecular medicine, 2020, Volume: 24, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Polymyxin B; Sesquiterpenes

2020
New Delhi Metallo-β-Lactamase-5-Producing Escherichia coli in Companion Animals, United States.
    Emerging infectious diseases, 2020, Volume: 26, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Records; Retrospective Studies; United States

2020
First Indian report on genome-wide comparison of multidrug-resistant Escherichia coli from blood stream infections.
    PloS one, 2020, Volume: 15, Issue:2

    Topics: Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genomics; Humans; India; Polymorphism, Single Nucleotide; Virulence; Whole Genome Sequencing

2020
Transcriptional response of mar, sox and rob regulon against concentration gradient carbapenem stress within Escherichia coli isolated from hospital acquired infection.
    BMC research notes, 2020, Mar-19, Volume: 13, Issue:1

    Topics: Carbapenems; Cross Infection; DNA-Binding Proteins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; India; Regulon; Trans-Activators

2020
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
    PloS one, 2020, Volume: 15, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult

2020
Identification of an extensively drug-resistant Escherichia coli clinical strain harboring mcr-1 and bla
    The Journal of antibiotics, 2020, Volume: 73, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Extraintestinal Pathogenic Escherichia coli; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Plasmids; Republic of Korea; Whole Genome Sequencing

2020
Challenges in the nursing care of intracranial carbapenem-resistant Escherichia coli infection after severe traumatic brain injury: a case report.
    Annals of palliative medicine, 2020, Volume: 9, Issue:4

    Topics: Brain Injuries, Traumatic; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Intracranial Hypertension

2020
The occurrence of Salmonella, extended-spectrum β-lactamase producing Escherichia coli and carbapenem resistant non-fermenting Gram-negative bacteria in a backyard poultry flock environment.
    Zoonoses and public health, 2020, Volume: 67, Issue:6

    Topics: Aged; Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chickens; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Housing, Animal; Humans; Salmonella; Salmonella Infections, Animal; Surveys and Questionnaires

2020
Risk factors for fecal carriage of extended-spectrum beta-lactamase-producing and carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains among patients at hospital admission.
    American journal of infection control, 2021, Volume: 49, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Risk Factors; Turkey

2021
Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy.
    The Journal of antimicrobial chemotherapy, 2020, 12-01, Volume: 75, Issue:12

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Europe; Humans; Italy; Microbial Sensitivity Tests; Plasmids; Swine

2020
Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, Nov-16, Volume: 77, Issue:Supplement

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Florida; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pharmacy Service, Hospital; Retrospective Studies; Urinary Tract Infections

2020
Cross-border emergence of clonal lineages of ST38 Escherichia coli producing the OXA-48-like carbapenemase OXA-244 in Germany and Switzerland.
    International journal of antimicrobial agents, 2020, Volume: 56, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Proteins; beta-Lactamases; Carbapenems; Cell Line, Tumor; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genome, Bacterial; Germany; HeLa Cells; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Switzerland; Whole Genome Sequencing

2020
Clinical and molecular characteristics of carbapenem non-susceptible Escherichia coli: A nationwide survey from Oman.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Databases, Genetic; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Genes, Bacterial; Humans; Infant; Infant, Newborn; Male; Middle Aged; Oman; Plasmids; Virulence Factors; Young Adult

2020
Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin.
    Nature communications, 2020, 10-16, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Auranofin; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests

2020
Emergence of carbapenem-resistant ST131
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2020, Volume: 25, Issue:46

    Topics: Adult; Aged; Carbapenems; Child; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Germany; Humans; Middle Aged; Young Adult

2020
Clinical syndromes and treatment location predict utility of carbapenem sparing therapies in ceftriaxone-non-susceptible Escherichia coli bloodstream infection.
    Annals of clinical microbiology and antimicrobials, 2020, Nov-30, Volume: 19, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Tazobactam

2020
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype

2020
Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae.
    Scientific reports, 2021, 01-08, Volume: 11, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Escherichia coli; Escherichia coli Infections; Female; Humans; Kaplan-Meier Estimate; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Treatment Outcome

2021
    Microbial genomics, 2021, Volume: 7, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Netherlands; Plasmids

2021
Detection of Extended-Spectrum Beta-Lactamase-Producing and Carbapenem-Resistant Bacteria from Mink Feces and Feed in the United States.
    Foodborne pathogens and disease, 2021, Volume: 18, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Feces; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mink; United States

2021
Colonization with selected antibiotic resistant bacteria among a cohort of Sri Lankan university students.
    BMC infectious diseases, 2021, Jun-15, Volume: 21, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Sri Lanka; Staphylococcal Infections; Students; Universities; Young Adult

2021
A Transferable IncC-IncX3 Hybrid Plasmid Cocarrying
    mSphere, 2021, 08-25, Volume: 6, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Plasmids; Tigecycline

2021
Co-localization of carbapenem (blaOXA-162) and colistin (mcr-1) resistance genes on a transferable IncHI2 plasmid in Escherichia coli of chicken origin.
    The Journal of antimicrobial chemotherapy, 2021, 10-11, Volume: 76, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Chickens; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids; Poultry Diseases

2021
Carbapenem resistance in a rural part of southern India:
    The Indian journal of medical research, 2016, Volume: 144, Issue:5

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests

2016
Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, May-15, Volume: 64, Issue:suppl_2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; DNA, Bacterial; Electronic Health Records; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Incidence; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Surveys and Questionnaires; Young Adult

2017
Efficacy of non-carbapenem antibiotics for pediatric patients with first febrile urinary tract infection due to extended-spectrum beta-lactamase-producing Escherichia coli.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Fever; Humans; Infant; Japan; Male; Retrospective Studies; Urinary Tract Infections

2017
Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017, Volume: 36, Issue:11

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Inappropriate Prescribing; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies

2017
First report of an Escherichia coli strain from swine carrying an OXA-181 carbapenemase and the colistin resistance determinant MCR-1.
    International journal of antimicrobial agents, 2017, Volume: 50, Issue:2

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Transfer, Horizontal; Italy; Multilocus Sequence Typing; Plasmids; Swine

2017
Expanding landscapes of the diversified mcr-1-bearing plasmid reservoirs.
    Microbiome, 2017, 07-06, Volume: 5, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fenoterol; Gene Deletion; Humans; Interspersed Repetitive Sequences; Plasmids; Replication Origin; Sequence Analysis, DNA; Swine

2017
Characterization of Carbapenem-Resistant Escherichia coli Isolates Through the Whole-Genome Sequencing Analysis.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Gene Expression; Genome, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Serogroup; Whole Genome Sequencing

2018
A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; France; Gene Expression; Genetic Variation; Hospitals; Humans; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids

2018
Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:14

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Tertiary Care Centers

2017
Genetic characterization of blaNDM-harboring plasmids in carbapenem-resistant Escherichia coli from Myanmar.
    PloS one, 2017, Volume: 12, Issue:9

    Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Myanmar; Phylogeny; Plasmids; Sequence Analysis, DNA

2017
Case report of transient mcr-1-haboring Escherichia coli with concurrent Staphylococcus aureus bacteremia in Long Beach, California.
    Diagnostic microbiology and infectious disease, 2017, Volume: 89, Issue:4

    Topics: Bacteremia; California; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Male; Middle Aged; Plasmids; Staphylococcal Infections; Staphylococcus aureus

2017
The use of cefepime as a carbapenem-sparing antibiotic for treating uncomplicated acute pyelonephritis caused by extended-spectrum β-lactamase producing Escherichia coli.
    Infectious diseases (London, England), 2018, Volume: 50, Issue:3

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cefepime; Cephalosporins; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pyelonephritis; Republic of Korea; Retrospective Studies; Risk Factors; Treatment Outcome

2018
Plasmid-mediated mcr-1 in carbapenem-susceptible Escherichia coli ST156 causing a blood infection: an unnoticeable spread of colistin resistance in Brazil?
    Clinics (Sao Paulo, Brazil), 2017, Volume: 72, Issue:10

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; Brazil; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Microbial Sensitivity Tests; Plasmids

2017
New Delhi metallo-β-lactamase - type carbapenemases producing
    The Indian journal of medical research, 2017, Volume: 146, Issue:1

    Topics: beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Urinary Tract Infections

2017
IncX3 Epidemic Plasmid Carrying
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3

    Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Gene Expression; Plasmids; Replicon; Swine

2018
Trends in Resistance to Extended-Spectrum Cephalosporins and Carbapenems among Escherichia coli and Klebsiella spp. Isolates in a District in Western India during 2004-2014.
    International journal of environmental research and public health, 2018, 01-19, Volume: 15, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests

2018
Molecular characterisation of bla
    Journal of global antimicrobial resistance, 2018, Volume: 13

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Farms; Feces; Genotype; India; Microbial Sensitivity Tests; Multilocus Sequence Typing; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Swine; Virulence

2018
Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran.
    Journal of global antimicrobial resistance, 2018, Volume: 14

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Carbapenems; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli Infections; Female; Genetic Variation; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Quinolones; Uropathogenic Escherichia coli; Virulence; Virulence Factors; Young Adult

2018
Novel variant NDM-11 and other NDM-1 variants in multidrug-resistant Escherichia coli from South India.
    Journal of global antimicrobial resistance, 2018, Volume: 14

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Snake Bites; Wound Infection

2018
Dissemination of
    Antimicrobial resistance and infection control, 2018, Volume: 7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Plasmids

2018
Detection of Antibiotic Resistance Determinants and Their Transmissibility among Clinically Isolated Carbapenem-Resistant Escherichia coli from South India.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2018, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Databases, Nucleic Acid; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; India; Male; Middle Aged; Polymerase Chain Reaction; Tertiary Care Centers; Young Adult

2018
Carbapenem-susceptible Escherichia coli ST3901 carrying mcr-1 and bla
    Journal of global antimicrobial resistance, 2018, Volume: 13

    Topics: beta-Lactamases; Brazil; Carbapenems; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Middle Aged

2018
A clinical isolate of Escherichia coli co-harbouring mcr-1 and blaNDM-5 in Japan.
    Journal of medical microbiology, 2018, Volume: 67, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genotype; Humans; Japan; Male; Molecular Typing; Plasmids

2018
Sharing more than friendship - transmission of NDM-5 ST167 and CTX-M-9 ST69
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018, Volume: 23, Issue:27

    Topics: Animals; beta-Lactamases; Carbapenems; Dogs; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Finland; Friends; Humans; Multilocus Sequence Typing; Pets; Polymerase Chain Reaction; Whole Genome Sequencing

2018
Antibiotic exposure elicits the emergence of colistin- and carbapenem-resistant Escherichia coli coharboring MCR-1 and NDM-5 in a patient.
    Virulence, 2018, Volume: 9, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids

2018
Molecular and Phenotypic Study of Carbapenem Resistant E. coli.
    Clinical laboratory, 2018, Jul-01, Volume: 64, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests

2018
Molecular characterization of Carbapenem resistant Escherichia coli recovered from a tertiary hospital in Lebanon.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Lebanon; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Serotyping; Tertiary Care Centers; Virulence

2018
Carbapenem-Sparing Therapy for Extended-Spectrum β-Lactamase-Producing E coli and Klebsiella pneumoniae Bloodstream Infection: The Search Continues.
    JAMA, 2018, 09-11, Volume: 320, Issue:10

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2018
Extended-spectrum β-lactamase-producing E. coli septicemia among rectal carriers in the ICU.
    Medicine, 2018, Volume: 97, Issue:38

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Cephalosporins; China; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Rectal Diseases; Retrospective Studies; Risk Factors

2018
High carriage rate of mcr-1 and antimicrobial resistance profiles of mcr-1-positive Escherichia coli isolates in swine faecal samples collected from eighteen provinces in China.
    Veterinary microbiology, 2018, Volume: 225

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Feces; Gene Transfer, Horizontal; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Swine; Swine Diseases; Tigecycline

2018
Early emergence of OXA-181-producing Escherichia coli ST410 in China.
    Journal of global antimicrobial resistance, 2018, Volume: 15

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Middle Aged; Multilocus Sequence Typing; Plasmids

2018
Infections Caused by Extended-Spectrum
    BioMed research international, 2018, Volume: 2018

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Humans; Lupus Erythematosus, Systemic; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Risk Factors

2018
Hidden Carbapenem Resistance in OXA-48 and Extended-Spectrum β-Lactamase-Positive
    Microbial drug resistance (Larchmont, N.Y.), 2019, Volume: 25, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Conjugation, Genetic; Croatia; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids

2019
Emergence of a multidrug-resistant clinical isolate of Escherichia coli ST8499 strain producing NDM-13 carbapenemase in the Republic of Korea.
    Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids; Republic of Korea

2019
Epidemiology and antimicrobial susceptibility profiles of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichiacoli in China.
    Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2019, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; China; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult

2019
Characterization of an NDM-5 carbapenemase-producing Escherichia coli ST156 isolate from a poultry farm in Zhejiang, China.
    BMC microbiology, 2019, 04-25, Volume: 19, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Farms; Genome, Bacterial; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Poultry; Virulence Factors

2019
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
    The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Laos; Male; Middle Aged; Public Health Surveillance

2019
Rapid Increase in Carbapenemase-Producing Enterobacteriaceae in Retail Meat Driven by the Spread of the
    Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:8

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meat; Microbial Sensitivity Tests; Plasmids

2019
Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
    Diagnostic microbiology and infectious disease, 2019, Volume: 95, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Culture Media; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Mutation; Plasmids; Recombinant Proteins; Surgical Wound Infection; Switzerland; Zinc

2019
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase.
    Nature communications, 2019, 08-06, Volume: 10, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Catalytic Domain; Cell Wall; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Zinc

2019
Alternatives to carbapenems in ESBL-producing Escherichia coli infections.
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Membrane Proteins; Microbial Sensitivity Tests; Sequence Alignment; Sequence Homology, Nucleic Acid

2013
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections; Urine

2013
Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China.
    PloS one, 2013, Volume: 8, Issue:6

    Topics: Aged; beta-Lactamases; Blotting, Southern; Carbapenems; China; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Transformation, Bacterial

2013
Verona integron-encoded metallo-β-lactamase 1 in Enterobacteria, Ontario, Canada.
    Emerging infectious diseases, 2013, Volume: 19, Issue:7

    Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Proteins; Bacteriuria; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Female; Humans; Integrons; Male; Middle Aged; Multilocus Sequence Typing

2013
Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.
    The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:12

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; DNA, Bacterial; Dogs; Escherichia coli; Escherichia coli Infections; Genotype; Germany; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA

2013
Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
    BMC infectious diseases, 2013, Dec-20, Volume: 13

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Multilocus Sequence Typing; Phylogeny; Taiwan

2013
Molecular characterization of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the countries of the Gulf cooperation council: dominance of OXA-48 and NDM producers.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle East; Oxytocin

2014
Use of outpatient parenteral antimicrobial therapy for transrectal ultrasound-guided prostate biopsy prophylaxis in the setting of community-associated multidrug-resistant Escherichia coli rectal colonization.
    Urology, 2014, Volume: 83, Issue:4

    Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitalization; Humans; Image-Guided Biopsy; Infusions, Parenteral; Male; Middle Aged; Outpatients; Prevalence; Prospective Studies; Prostate; Prostatitis; Rectum; Ultrasonography, Interventional

2014
Biochemical analysis of metallo-β-lactamase NDM-3 from a multidrug-resistant Escherichia coli strain isolated in Japan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Plasmids

2014
I read about infections from the so-called "superbugs." Is antibiotic resistance increasing?
    Mayo Clinic health letter (English ed.), 2013, Volume: 31, Issue:9

    Topics: beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; United States

2013
Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefoxitin; Drug Administration Schedule; Drug Dosage Calculations; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Models, Statistical; Pyelonephritis; Urinary Tract Infections

2014
Risk factors for the acquisition of carbapenem-resistant Escherichia coli at a tertiary care center in South Korea: a matched case-control study.
    American journal of infection control, 2014, Volume: 42, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Republic of Korea; Retrospective Studies; Risk Factors; Tertiary Care Centers

2014
Complete sequencing of IncI1 sequence type 2 plasmid pJIE512b indicates mobilization of blaCMY-2 from an IncA/C plasmid.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Citrobacter freundii; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Interspersed Repetitive Sequences; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphoproteins; Plasmids; Sequence Alignment

2014
The determination of carbapenem resistance in Escherichia coli and Pneumoniae isolates related to nosocomial infections and the evaluation of risk factors.
    The Southeast Asian journal of tropical medicine and public health, 2014, Volume: 45, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Risk Factors

2014
Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern.
    Journal of applied microbiology, 2014, Volume: 117, Issue:4

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Molecular Sequence Data; Phylogeny; Quinolones; Wastewater

2014
Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2015, Volume: 48, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacteriaceae; Escherichia coli Infections; Female; Hospitals; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Survival Analysis; Taiwan

2015
Unexpected in vivo activity of ceftazidime alone and in combination with avibactam against New Delhi metallo-β-lactamase-producing Enterobacteriaceae in a murine thigh infection model.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11

    Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests

2014
Efforts mount to curb carbapenem-resistant infections.
    JAMA, 2014, Oct-08, Volume: 312, Issue:14

    Topics: Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Infection Control; Klebsiella Infections; Practice Guidelines as Topic; United States

2014
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    BMC infectious diseases, 2014, Nov-25, Volume: 14

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections

2014
Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:3

    Topics: Aged; Aged, 80 and over; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Endodeoxyribonucleases; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Genome, Bacterial; Hospitals; Humans; Interspersed Repetitive Sequences; Male; Middle Aged; Molecular Sequence Data; Phylogeny; Plasmids; Replicon; Sequence Alignment; Sequence Analysis, DNA; Serratia Infections; Serratia marcescens

2015
Detection of OXA-48-like carbapenemase genes by the Xpert® Carba-R test: room for improvement.
    International journal of antimicrobial agents, 2015, Volume: 45, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Genetic Variation; Humans; Male; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Sensitivity and Specificity

2015
Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines.
    Gastrointestinal endoscopy, 2015, Volume: 81, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cholangiopancreatography, Endoscopic Retrograde; Cross Infection; Disinfection; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Guidelines as Topic; Humans; Male; Middle Aged; Young Adult

2015
Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015, Volume: 21, Issue:5

    Topics: Aged; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; China; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Prevalence; Risk Factors

2015
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis.
    Journal of pharmacy practice, 2016, Volume: 29, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome

2016
Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak.
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:6

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporin Resistance; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male; Microbial Sensitivity Tests; Middle Aged

2015
ERCP scopes: what can we do to prevent infections?
    Infection control and hospital epidemiology, 2015, Volume: 36, Issue:6

    Topics: Carbapenems; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Disease Outbreaks; Duodenoscopes; Equipment Contamination; Escherichia coli; Escherichia coli Infections; Female; Humans; Infection Control; Male

2015
[Evaluation of Antibiotics for the Treatment of Bacteremia Due to Extended-spectrum β-Lactamase-producing Escherichia coli].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2015, Volume: 135, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cefmetazole; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Young Adult

2015
Characterization of Multidrug Resistant Extended-Spectrum Beta-Lactamase-Producing Escherichia coli among Uropathogens of Pediatrics in North of Iran.
    BioMed research international, 2015, Volume: 2015

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Iran; Male; Urinary Tract Infections

2015
Prevalence study on carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates in Czech hospitals--results from Czech Part of European Survey on Carbapenemase--Producing Enterobacteriaceae (EuSCAPE).
    Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2015, Volume: 64, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Czech Republic; Escherichia coli; Escherichia coli Infections; Geography; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Ukraine

2015
Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Infectious diseases (London, England), 2015, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Young Adult

2015
Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:5

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mongolia; Plasmids; Polymerase Chain Reaction

2016
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2015, Volume: 39

    Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cohort Studies; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Young Adult

2015
Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospectiv
    International journal of antimicrobial agents, 2015, Volume: 46, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome

2015
In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefepime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Microbial Sensitivity Tests; Molecular Docking Simulation

2015
Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2017, Volume: 50, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult

2017
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    BMC infectious diseases, 2015, Oct-13, Volume: 15

    Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pyelonephritis; Republic of Korea; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Uropathogenic Escherichia coli

2015
Association of Risk Factors, Antimicrobial Resistance Trends and Occurrence of blaTEM, bla SHV and blaCTX M in Escherichia coli Causing Bacteremia.
    Infectious disorders drug targets, 2016, Volume: 16, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Diabetes Complications; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Phenotype; Polymerase Chain Reaction; Prospective Studies; Risk Factors; Urinary Tract Infections

2016
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Molecules (Basel, Switzerland), 2016, Jan-06, Volume: 21, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tablets

2016
[Clinical features and antibiotic resistance of Escherichia coli bloodstream infections in children].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2016, Volume: 54, Issue:2

    Topics: Adolescent; Bacteremia; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections

2016
First Description of IncX3 Plasmids Carrying blaOXA-181 in Escherichia coli Clinical Isolates in Burkina Faso.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:5

    Topics: Aged; beta-Lactamases; Burkina Faso; Carbapenems; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Male; Microbial Sensitivity Tests; Plasmids; Young Adult

2016
Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report.
    Medicine, 2016, Volume: 95, Issue:7

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Kidney Transplantation; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Surgical Wound Infection; Thienamycins

2016
Fecal Carriage of Extended-Spectrum β-Lactamases in Healthy Humans, Poultry, and Wild Birds in León, Nicaragua-A Shared Pool of bla
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:8

    Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carrier State; Clone Cells; Columbidae; Epidemiological Monitoring; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Falconiformes; Feces; Gene Expression Regulation, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Nicaragua; Poultry; Sequence Analysis, DNA

2016
High-level carbapenem-resistant OXA-48-producing Klebsiella pneumoniae with a novel OmpK36 variant and low-level, carbapenem-resistant, non-porin-deficient, OXA-181-producing Escherichia coli from Thailand.
    Diagnostic microbiology and infectious disease, 2016, Volume: 85, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fatal Outcome; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Typing; Porins; Thailand; Young Adult

2016
blaNDM-5-carrying IncX3 plasmid in Escherichia coli ST1284 isolated from raw milk collected in a dairy farm in Algeria.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:9

    Topics: Algeria; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Escherichia coli Infections; Farms; Milk; Plasmids; Raw Foods

2016
[The clinical characteristics analysis of Escherichia coli bloodstream infection].
    Zhonghua yi xue za zhi, 2016, May-17, Volume: 96, Issue:18

    Topics: Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors

2016
More Furious Than Ever: Escherichia coli-Acquired Co-resistance Toward Colistin and Carbapenems.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, 11-01, Volume: 63, Issue:9

    Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Microbial Sensitivity Tests; Plasmids

2016
Colistin- and Carbapenem-Resistant Escherichia coli Harboring mcr-1 and blaNDM-5, Causing a Complicated Urinary Tract Infection in a Patient from the United States.
    mBio, 2016, 08-30, Volume: 7, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Male; Plasmids; Sequence Analysis, DNA; Sequence Homology; Travel; United States; Urinary Tract Infections; Urine

2016
IncFII Conjugative Plasmid-Mediated Transmission of blaNDM-1 Elements among Animal-Borne Escherichia coli Strains.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Gene Expression; Plasmids; Prevalence; Swine; Swine Diseases

2017
Various Sequence Types of Escherichia coli Isolates Coharboring
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:3

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Transfer, Horizontal; Genetic Fitness; Genotype; Plasmids; Swine; Swine Diseases

2017
OXA-48-producing ST372 Escherichia coli in a French dog.
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Animals; beta-Lactamases; Carbapenems; Cats; Cephalosporins; Dogs; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins

2017
Isolation of Escherichia coli ST131 producing KPC-2 in Bulgaria.
    Infectious diseases (London, England), 2017, Volume: 49, Issue:5

    Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Bulgaria; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefotaxime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Microbial Sensitivity Tests; Phylogeny; Plasmids

2017
Strain-specific transmission in an outbreak of ESBL-producing Enterobacteriaceae in the hemato-oncology care unit: a cohort study.
    BMC infectious diseases, 2017, 01-05, Volume: 17, Issue:1

    Topics: Adult; Aged; beta-Lactamases; Carbapenems; Cohort Studies; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospital Units; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Polymerase Chain Reaction; Young Adult

2017
Risk factors and medical costs for healthcare-associated carbapenem-resistant Escherichia coli infection among hospitalized patients in a Chinese teaching hospital.
    BMC infectious diseases, 2017, 01-17, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Case-Control Studies; Catheterization, Central Venous; Child; Child, Preschool; China; Cross Infection; Drug Costs; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Health Care Costs; Hemoglobins; Hospitals, Teaching; Humans; Hyperglycemia; Incidence; Infant; Infant, Newborn; Length of Stay; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tertiary Care Centers; Tracheostomy; Urologic Diseases; Young Adult

2017
Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward.
    Investigative and clinical urology, 2017, Volume: 58, Issue:1

    Topics: Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Catheters, Indwelling; Cross Infection; Cystectomy; Drug Resistance, Microbial; Enterococcus; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospital Units; Humans; Immunosuppression Therapy; Incidence; Klebsiella; Klebsiella Infections; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Surgical Wound Infection; Urinary Catheters; Urinary Tract Infections; Urology; Vancomycin

2017
Occurrence of bla
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017, Volume: 23, Issue:4

    Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Conjugation, Genetic; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; India; Plasmids

2017
Occurrence of bla
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7

    Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers; Transcription, Genetic

2017
Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Gene Expression; Humans; Kuwait; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Oman; Phylogeny; Plasmids; Saudi Arabia; Tigecycline; United Arab Emirates

2017
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
    BMC infectious diseases, 2017, 02-10, Volume: 17, Issue:1

    Topics: Anti-Infective Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Escherichia coli; Escherichia coli Infections; Female; Hospitals, Teaching; Humans; Incidence; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Sri Lanka; Urinary Tract Infections

2017
High Carbapenem Resistance in Clinical Gram-Negative Pathogens Isolated in Egypt.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Gene Expression; Hospitals; Humans; Integrons; Microbial Sensitivity Tests; Morganella morganii; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia Infections; Serratia marcescens

2017
Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate.
    International journal of antimicrobial agents, 2017, Volume: 49, Issue:4

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans

2017
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Infection control and hospital epidemiology, 2008, Volume: 29, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Predictive Value of Tests

2008
Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients.
    Diagnostic microbiology and infectious disease, 2008, Volume: 62, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Odds Ratio; Risk Factors

2008
Emergence of carbapenem-resistant Escherichia coli producing CMY-2-type AmpC beta-lactamase in Brazil.
    Journal of medical microbiology, 2008, Volume: 57, Issue:Pt 12

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fatal Outcome; Humans; Male; Microbial Sensitivity Tests; Middle Aged

2008
Carbapenem-resistant Escherichia coli carrying the blaVIM-1 gene in the community.
    International journal of antimicrobial agents, 2009, Volume: 34, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Humans; Male

2009
Klebsiella pneumoniae Carbapenemase-producing Enterobacteriaceae, Northeast Florida.
    Southern medical journal, 2009, Volume: 102, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Florida; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult

2009
Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems us
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colony Count, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Microbial Viability; Minocycline; Models, Theoretical; Serum; Tigecycline

2009
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic

2010
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:6

    Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fosfomycin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2010
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Academic Medical Centers; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Israel; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Time Factors

2010
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin

2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae

2010
Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2010, Volume: 29, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporinase; Drug Resistance, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Porins; Taiwan

2010
Global spread of New Delhi metallo-β-lactamase 1.
    The Lancet. Infectious diseases, 2010, Volume: 10, Issue:12

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Netherlands; Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus aureus; Travel

2010
Emergence of VIM-1 metallo-β-lactamase-producing Escherichia coli in a neonatal intensive care unit.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Greece; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Plasmids; Polymerase Chain Reaction

2011
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection.
    Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Urinary Tract Infections; Young Adult

2010
Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011, Volume: 30, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Citrobacter freundii; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins

2011
Efficacy of carbapenems against a metallo-β-lactamase-producing Escherichia coli clinical isolate in a rabbit intra-abdominal abscess model.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:3

    Topics: Abdominal Abscess; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Humans; Male; Rabbits; Rodent Diseases; Treatment Outcome

2011
New Delhi metallo-beta-lactamase from traveler returning to Canada.
    Emerging infectious diseases, 2011, Volume: 17, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine

2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome

2011
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: a matched case-control study.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Escherichia coli; Escherichia coli Infections; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Liver Diseases; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Regression Analysis; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome; Uremia

2011
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
    International urology and nephrology, 2012, Volume: 44, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin

2012
Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    The Journal of the Association of Physicians of India, 2010, Volume: 58 Suppl

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Hospitals, University; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Risk Factors; Treatment Outcome; Young Adult

2010
Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E coli from Trinidad and Tobago.
    The West Indian medical journal, 2010, Volume: 59, Issue:6

    Topics: Aminoglycosides; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Trinidad and Tobago

2010
When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10

    Topics: Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; France; Humans; Middle Aged; Multilocus Sequence Typing; Urine

2011
Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Urology, 2011, Volume: 78, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy, Needle; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Prevalence; Prostate; Prostatitis; Rectum

2011
Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.
    Chemotherapy, 2011, Volume: 57, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Blood; Cancer Care Facilities; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Retrospective Studies; United States; Urine

2011
A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:12

    Topics: Adult; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genetic Variation; Humans; India; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; United Kingdom

2011
Identification of a plasmid-borne blaIMP-11 gene in clinical isolates of Escherichia coli and Klebsiella pneumoniae.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Infant; Infant, Newborn; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sequence Analysis, DNA; Sequence Homology

2012
First detection of blaIMI-2 gene in a clinical Escherichia coli strain.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA

2012
Efficacy of doripenem against Escherichia coli and Klebsiella pneumoniae in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Cefepime; Cephalosporins; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meningitis, Bacterial; Rabbits; Treatment Outcome

2012
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Cefoxitin; Ceftriaxone; Conjugation, Genetic; Disease Models, Animal; Drug Administration Schedule; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Kidney; Mice; Microbial Sensitivity Tests; Mutation Rate; Plasmids; Urinary Bladder; Urinary Tract Infections

2012
Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Genes, Bacterial; Greece; Hospitals; Humans; Isoelectric Focusing; Klebsiella pneumoniae; Long-Term Care; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Skilled Nursing Facilities

2012
High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Bulgaria; Carbapenems; Clone Cells; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Phylogeny; Population Surveillance; Random Amplified Polymorphic DNA Technique

2012
Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Child, Preschool; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Infections; Humans; Infant; Integrases; Malaysia; Microbial Sensitivity Tests; Phylogeny; Prevalence; Tertiary Care Centers

2012
High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China.
    Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:4

    Topics: Anti-Bacterial Agents; Asymptomatic Diseases; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; China; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli Infections; Humans; Infant; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Mutation; Nasopharynx; Phylogeny; Prevalence; RNA, Ribosomal, 23S

2012
A permission system for carbapenem use reduced incidence of drug-resistant bacteria and cost of antimicrobials at a general hospital in Japan.
    Nagoya journal of medical science, 2012, Volume: 74, Issue:1-2

    Topics: Anti-Bacterial Agents; Carbapenems; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli Infections; Feasibility Studies; Hospital Costs; Hospitals, General; Humans; Inappropriate Prescribing; Infection Control; Japan; Klebsiella Infections; Medical Order Entry Systems; Pharmacy Service, Hospital; Practice Patterns, Physicians'; Program Evaluation; Pseudomonas Infections; Retrospective Studies; Time Factors

2012
Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2016
Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon.
    Journal of infection in developing countries, 2012, May-14, Volume: 6, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lebanon

2012
Use of meropenem Adatabs dissolved in MacConkey agar for screening NDM-1 positive Enterobacteriaceae in faecal surveillance cultures.
    Pathology, 2012, Volume: 44, Issue:5

    Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Culture Media; Drug Stability; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins

2012
Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.
    Intensive care medicine, 2012, Volume: 38, Issue:11

    Topics: Aged; Antibiotic Prophylaxis; beta-Lactam Resistance; Carbapenems; Carrier State; Community-Acquired Infections; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Female; France; Humans; Intensive Care Units; Male; Middle Aged; Multivariate Analysis; Prevalence; Prospective Studies; Risk Factors

2012
KPC-9, a novel carbapenemase from clinical specimens in Israel.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11

    Topics: Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Escherichia coli; Escherichia coli Infections; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids

2012
Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013, Volume: 17, Issue:2

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cephalosporins; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests

2013
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae strains containing New Delhi metallo-beta-lactamase isolated from two patients in Vietnam.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:1

    Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Vietnam

2013
Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multihospital study.
    Infection control and hospital epidemiology, 2012, Volume: 33, Issue:12

    Topics: Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier State; Case-Control Studies; Chicago; Community-Acquired Infections; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Odds Ratio; Prevalence; Propensity Score; Rectum; Respiration, Artificial; Skilled Nursing Facilities

2012
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates.
    World journal of urology, 2013, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult

2013
Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital: clinical spectrum.
    Annals of the Academy of Medicine, Singapore, 2004, Volume: 33, Issue:3

    Topics: Aged; beta-Lactamases; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged

2004
Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2005, Volume: 38, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization; Cefmetazole; Cefotaxime; Child; Child, Preschool; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Heart Defects, Congenital; Humans; Immunologic Deficiency Syndromes; Infant; Inpatients; Klebsiella Infections; Klebsiella pneumoniae; Male; Neoplasms; Premature Birth; Taiwan

2005
Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    International journal of antimicrobial agents, 2005, Volume: 26, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Critical Care; Diabetes Complications; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Treatment Outcome

2005
[The proper use of carbapenem examined by Monte Carlo simulation].
    The Japanese journal of antibiotics, 2005, Volume: 58, Issue:3

    Topics: Carbapenems; Escherichia coli Infections; Humans; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections

2005
Clinical features of nosocomial infections by extended-spectrum beta-lactamase-producing Enterobacteriaceae in neonatal intensive care units.
    Acta paediatrica (Oslo, Norway : 1992), 2005, Volume: 94, Issue:11

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome

2005
Prior use of carbapenems may be a significant risk factor for extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia.
    The Journal of antimicrobial chemotherapy, 2006, Volume: 58, Issue:5

    Topics: Adult; Aged; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; Retrospective Studies; Risk Factors

2006
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Apr-01, Volume: 44, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Incidence; Male; Microbial Sensitivity Tests; New York City; Polymerase Chain Reaction; Population Surveillance

2007
Extended-spectrum beta-lactamases in ceftazidime-resistant Escherichia coli and Klebsiella pneumoniae isolates in Turkish hospitals.
    Indian journal of medical microbiology, 2007, Volume: 25, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Turkey

2007
Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    The Journal of hospital infection, 2008, Volume: 68, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Hong Kong; Humans; Retrospective Studies; Treatment Outcome; Urinary Tract Infections

2008
Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 61, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Taiwan

2008
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
    International journal of antimicrobial agents, 2008, Volume: 31, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey

2008
Efficacy of meropenem in experimental meningitis.
    The Journal of antimicrobial chemotherapy, 1995, Volume: 36 Suppl A

    Topics: Ampicillin; Animals; Carbapenems; Ceftazidime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Proteins; Drug Evaluation; Drug Resistance, Microbial; Escherichia coli Infections; Gentamicins; Guinea Pigs; Haemophilus Infections; Haemophilus influenzae; Listeriosis; Meningitis, Bacterial; Meropenem; Neisseria meningitidis; Penicillin G; Pneumococcal Infections; Thienamycins

1995
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids

1997
Convergent syntheses of oral THF 1beta-methylcarbapenems.
    The Journal of antibiotics, 1999, Volume: 52, Issue:7

    Topics: Animals; Bacteria; Carbapenems; Escherichia coli Infections; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Spectrometry, Mass, Fast Atom Bombardment; Staphylococcal Infections

1999
Synthesis and antibacterial activity of 2alpha-functionalized 1beta-methylcarbapenems related to KR-21012.
    Bioorganic & medicinal chemistry letters, 2000, Feb-21, Volume: 10, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Stability; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Streptococcal Infections; Structure-Activity Relationship; Survival Rate

2000
In vitro and in vivo antibacterial activities of a new injectable carbapenem, S-4661, against gynaecological pathogens.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Microbial Sensitivity Tests; Rats; Uterine Diseases

2000
Urinary tract infection in neurogenic bladder.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:4

    Topics: Acute Disease; Anti-Infective Agents, Urinary; Carbapenems; Cephalosporins; Chronic Disease; Epididymitis; Escherichia coli Infections; Female; Fever; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Male; Prostatitis; Pseudomonas Infections; Pyelonephritis; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Catheterization; Urinary Tract Infections

2001
Synthesis and antibacterial activity of some novel 6-methyl- and 6-propenyl-substituted carbapenems.
    Journal of medicinal chemistry, 1992, Mar-06, Volume: 35, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Stability; Escherichia coli Infections; Mice; Molecular Structure; Stereoisomerism; Structure-Activity Relationship

1992
Synthesis and antibacterial activity of C-2 carboxyethenylthio-carbapenem derivatives.
    The Journal of antibiotics, 1990, Volume: 43, Issue:7

    Topics: Animals; Bacteria; Carbapenems; Chemical Phenomena; Chemistry; Culture Techniques; Drug Stability; Escherichia coli Infections; Humans; Kidney; Mice; Molecular Conformation; Molecular Structure; Staphylococcal Infections; Stereoisomerism

1990
Evaluation of FCE 22101 in experimental meningitis caused by Escherichia coli and Streptococcus pneumoniae.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl C

    Topics: Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Carbapenems; Ceftriaxone; Escherichia coli Infections; Imipenem; Meningitis; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Rabbits

1989
Therapeutic activity of meropenem in experimental infections.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 24 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Escherichia coli Infections; Guinea Pigs; Immunosuppression Therapy; Lung Diseases; Male; Meropenem; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Pseudomonas Infections; Respiratory Tract Infections; Thienamycins; Urinary Tract Infections

1989
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
    The Journal of antibiotics, 1986, Volume: 39, Issue:7

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1986